Lu S, Bischoff K, Rich J, Liu S, Skory C
Biotechnol Biofuels. 2020; 13:157.
PMID: 32944073
PMC: 7488000.
DOI: 10.1186/s13068-020-01795-9.
Lebeer S, Vanderleyden J, de Keersmaecker S
Microbiol Mol Biol Rev. 2008; 72(4):728-64, Table of Contents.
PMID: 19052326
PMC: 2593565.
DOI: 10.1128/MMBR.00017-08.
Yano T, Mita S, Ohmori H, Oshima Y, Fujimoto Y, Ueda R
Nat Immunol. 2008; 9(8):908-16.
PMID: 18604211
PMC: 2562576.
DOI: 10.1038/ni.1634.
Kumar A, Ray P, Kanwar M, Sharma M, Varma S
Int J Med Sci. 2005; 2(4):129-36.
PMID: 16239950
PMC: 1252724.
DOI: 10.7150/ijms.2.129.
Grundmann H, Weiss H, Trachsel H, STORCK H
Arch Dermatol Res. 1980; 267(3):291-9.
PMID: 7406538
DOI: 10.1007/BF00403850.
Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.
Matsumoto K, Ogawa H, Kusama T, NAGASE O, Sawaki N, Inage M
Infect Immun. 1981; 32(2):748-58.
PMID: 7019079
PMC: 351510.
DOI: 10.1128/iai.32.2.748-758.1981.
Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.
Matsumoto K, Otani T, Une T, Osada Y, Ogawa H, Azuma I
Infect Immun. 1983; 39(3):1029-40.
PMID: 6341226
PMC: 348060.
DOI: 10.1128/iai.39.3.1029-1040.1983.
Cross-reactivity between haptenic muramyl di- or tripeptide derivatives and Mycobacterium bovis BCG: potential application for enhancing tumor immunity.
Kosugi A, Shima J, Sano H, Ogata M, Kusama T, Fujiwara H
Infect Immun. 1986; 54(3):768-73.
PMID: 3491048
PMC: 260235.
DOI: 10.1128/iai.54.3.768-773.1986.
Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).
Akasaki M, Takashi T, Kita Y, Tsukada W
Agents Actions. 1987; 22(1-2):144-50.
PMID: 3318323
DOI: 10.1007/BF01968830.
Structural requirements of muramylpeptides for induction of necrosis at sites primed with Mycobacterium tuberculosis in guinea pigs.
Nagao S, Takada H, YAGAWA K, Kutsukake H, Shiba T, Kusumoto S
Infect Immun. 1987; 55(5):1279-88.
PMID: 3106217
PMC: 260502.
DOI: 10.1128/iai.55.5.1279-1288.1987.
Macrophages are stimulated by muramyl dipeptide to induce polymorphonuclear leukocyte accumulation in the peritoneal cavities of guinea pigs.
Nagao S, Nakanishi M, Kutsukake H, YAGAWA K, Kusumoto S, Shiba T
Infect Immun. 1990; 58(2):536-42.
PMID: 2298491
PMC: 258490.
DOI: 10.1128/iai.58.2.536-542.1990.
Synergistic effect of polyriboinosinic acid:polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats.
Kohashi O, Kotani S, Shiba T, Ozawa A
Infect Immun. 1979; 26(2):690-7.
PMID: 546792
PMC: 414671.
DOI: 10.1128/iai.26.2.690-697.1979.
Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.
Ohkuni H, Norose Y, Ohta M, Hayama M, Kimura Y, Tsujimoto M
Infect Immun. 1979; 24(2):313-8.
PMID: 457277
PMC: 414303.
DOI: 10.1128/iai.24.2.313-318.1979.
Inhibition of macrophage migration by muramyl peptides.
Nagao S, Tanaka A, Yamamoto Y, Koga T, Onoue K, Shiba T
Infect Immun. 1979; 24(2):308-12.
PMID: 457276
PMC: 414302.
DOI: 10.1128/iai.24.2.308-312.1979.
Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide.
Kireszenbaum F, FERRARESI R
Infect Immun. 1979; 25(1):273-8.
PMID: 113344
PMC: 414448.
DOI: 10.1128/iai.25.1.273-278.1979.
Rheumatoid arthritis: review of searches for an infectious cause. Part II.
Wilkes E, MEEK E
Infection. 1979; 7(4):192-7.
PMID: 92461
DOI: 10.1007/BF01640944.
Role of Staphylococcus aureus cell wall antigens in the stimulation of delayed hypersensitivity after staphylococcal infection.
Easmon C, GLYNN A
Infect Immun. 1978; 19(1):341-2.
PMID: 75189
PMC: 414085.
DOI: 10.1128/iai.19.1.341-342.1978.
Mycobacterium.
Barksdale L, Kim K
Bacteriol Rev. 1977; 41(1):217-372.
PMID: 67839
PMC: 414000.
DOI: 10.1128/br.41.1.217-372.1977.